UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Apollon Wealth Management LLC

Apollon Wealth Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.1% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,509 shares of the healthcare conglomerate's stock after purchasing an additional 975 shares during the period. Apollon Wealth Management LLC's holdings in UnitedHealth Group were worth $17,027,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of UNH. Citizens National Bank Trust Department lifted its holdings in UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after buying an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH grew its stake in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after purchasing an additional 1,465 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $515,000. Full Sail Capital LLC grew its position in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after buying an additional 33 shares in the last quarter. Finally, Soros Fund Management LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $39,413,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director John H. Noseworthy bought 300 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the acquisition, the director owned 6,063 shares of the company's stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock worth $31,607,768 over the last three months. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

UNH traded down $3.73 during trading on Monday, hitting $300.37. The stock had a trading volume of 10,659,781 shares, compared to its average volume of 11,129,027. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market capitalization of $272.48 billion, a P/E ratio of 12.58, a PEG ratio of 1.46 and a beta of 0.45. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company's 50-day moving average price is $314.52 and its 200 day moving average price is $439.94.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the previous year, the firm posted $6.91 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.94%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's payout ratio is 37.02%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on UNH. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Robert W. Baird cut UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price objective for the company. in a research report on Wednesday, June 11th. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. KeyCorp cut their price objective on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a report on Monday, June 2nd. Finally, Morgan Stanley lowered their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average target price of $415.00.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.